Patents
Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
11/2008
11/27/2008US20080293678 Organic Nitric Oxide Donor Salts of Angiotensin Converting Enzyme Inhibitors, Compositions and Methods of Use
11/26/2008EP1994413A2 Mass tags for quantitative analyses
11/26/2008EP1438296B1 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1- antagonistic activity
11/26/2008CN101311171A Compound with dual restraining activities to acetyl cholinesterase and butyryl cholinesterase and use thereof
11/26/2008CN100436433C High-purity piperazine pyrophosphate and method for producing same
11/26/2008CN100436425C Fused imidazolium derivatives
11/25/2008US7456283 an N-phenyl-4-(4-methyl-piperazin-1-ylmethyl)-benzamide claimed intermediate easily prepared by amidation of the aniline and the benzoic acid; reaction with a 2-aminopyrimidine to produce antitumor tyrosine kinase inhibitor
11/25/2008US7456218 3-(4-{[4'-(benzyloxy)-2',6'-dimethylbiphenyl-3-yl]methoxy}-2-fluorophenyl)propanoic acid; superior GPR40 receptor function modulating action, can be used as an insulin secretagogue, an agent for the prophylaxis or treatment of diabetes
11/25/2008US7456203 for treatment/prevention of chronic obstructive pulmonary disease, chronic bronchitis, irritable bowel syndrome, and urinary incontinence
11/25/2008US7456196 Alzheimer's disease; antihistamine; attention deficit disorder; hyperactivity; bipolar disorder; cognition activators; psychological disorder; anticancer agent; antidepressants; antiepileptic agents; gastrointestinal disorder; analgesics; 6-{2-[(2R)-2-methyl-1-pyrrolidinyl]ethyl}-2-(3-pyridinyl)quinoline
11/25/2008US7456158 4-dedimethylaminotetracycline derivatives
11/25/2008US7456133 Substituted arylketones
11/25/2008CA2414146C Substituted benzamides for immune enhancement and for the treatment of cancer, infection and manic-depressive illness
11/25/2008CA2380766C Calcium complex of phosphorus containing diethylenetriamine derivatives
11/25/2008CA2276588C New o-acyloxime photoinitiators
11/20/2008WO2008138639A1 Substituted phenylamino-benzene derivatives useful for treating hyper-proliferative disorders and diseases associated with mitogen extracellular kinase activity
11/20/2008WO2007067575A3 Process for preparing substituted aryl cycloalkanol derivatives
11/20/2008US20080287455 Sulfanyl substituted phenyl methanones
11/20/2008US20080287442 Organic Compounds
11/20/2008US20080287419 Apoptosis promoters
11/20/2008CA2756796A1 Novel solvate and crystalline forms of carbamoyl-cyclohexane derivatives
11/20/2008CA2686484A1 Substituted phenylamino-benzene derivatives useful for treating hyper-proliferative disorders and diseases associated with mitogen extracellular kinase activity
11/19/2008EP1991528A2 Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof
11/19/2008EP1692093B1 Biphenyl derivatives useful as ligands that activate the rar receptors, process for preparing them and use thereof in human medicine and in cosmetics
11/19/2008EP1687262B1 Bicyclic amide, carbamate or urea derivatives as vanilloid receptor modulators
11/19/2008EP1137798B1 A method of isolating stem cells
11/19/2008CN101309914A Method for producing ionic liquids
11/19/2008CN101309913A Process for the preparation of delmopinol and derivatives thereof
11/19/2008CN101309909A 2-phenylethylamino derivatives as calcium and/or sodium channel modulators
11/19/2008CN101309902A Biphenyl derivatives and their use in treating hepatitis c
11/19/2008CN101307038A 4- benzyl piperazi ethyliminumacyl (formimidoyl benzol)hydrazine compounds, preparation method thereof, pharmaceutical compositions and use
11/19/2008CN101307017A Amino-methyl substituted tetracycline compounds
11/19/2008CN100434421C Substituted propane-1,3-diamine derivatives and the pharmaceutical use
11/18/2008US7452921 for use in radiation curing; printing inks or varnishes; 4-Piperazinoacetophenone
11/18/2008US7452891 MCH antagonists and their use in the treatment of obesity
11/18/2008US7452878 Biaromatic compounds which activate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereof
11/18/2008CA2331187C Water soluble azoles as broad-spectrum antifungals
11/18/2008CA2230516C Pyrimidine derivatives
11/13/2008WO2008136378A1 Novel sulfonamide derivative and salt thereof
11/13/2008WO2008135980A1 Imatinib production process
11/13/2008WO2008114275A3 Anthranilic acid derivatives as anticancer agents and process for the preparation thereof
11/13/2008WO2008113359A3 1- [2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of pain or residual symptoms in depression relating to sleep and cognition
11/13/2008WO2007147839A9 Glycine transporter inhibiting compounds and uses in medicine
11/13/2008US20080281095 Asparatyl protease inhibitor
11/13/2008US20080280886 Substituted ureas
11/13/2008US20080280875 Fused phenyl amido heterocyclic compounds
11/13/2008US20080280769 Selective and dual-action p53/mdm2/mdm4 antagonists
11/12/2008EP1988902A2 Piperazine derivatives
11/12/2008EP1644340B1 N-[({'4-substituted piperazine-1-yl}sulfonylmethyl)alkyl]-n-hydroxyformamide compounds as metalloproteinase inhibitors
11/12/2008EP1409468B1 Guanidinobenzamides as mc4-r agonists
11/12/2008CN101302205A Preparation of piperazine acidamide compound
11/12/2008CN101302172A 3,5-diiodosalicylaldehyde Schiff alkali, preparation and use thereof
11/12/2008CN100432062C Terphenyl derivatives, preparation thereof, compositions containing same
11/11/2008US7449577 dehydration condensation of piperazine diphosphate; component of a flame retardant composition added to synthetic resins
11/11/2008US7449493 N-[2-[[1-[[[(2,4-dimethylphenyl)methyl]amino]methyl]cyclohexyl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide; monocyte chemoattractant proteins receptor antagonists or partial agonists/antagonists; antiinflammatory agent, autoimmune diseases; rheumatoid arthritis, multiple sclerosis, atherosclerosis
11/11/2008US7449485 N-sulfonylurea apoptosis promoters
11/11/2008US7449481 Thio-substituted biaryl-methanesulfinyl derivatives
11/11/2008US7449479 Hepatitis C virus inhibitors
11/11/2008US7449466 Cyclic aminophenyl sulfamate derivative
11/06/2008WO2008134474A2 Compositions and methods including cell death inducers and procaspase activation
11/06/2008WO2008134432A1 Proteinase inhibitors and uses thereof
11/06/2008WO2008134429A1 Cysteine proteinase inhibitors and uses thereof
11/06/2008WO2008133937A2 Compositions of tolperisone
11/06/2008WO2008133269A1 Ionic liquid, and polymer treatment agent comprising the ionic liquid
11/06/2008WO2008131947A1 Substituted sulfonamide derivatives
11/06/2008WO2008131860A2 Pyridonecarboxamides crop protection agents containing the same method for production and use thereof
11/06/2008WO2008131469A2 Method for the production of highly pure 2,4'-dimethyl-3-piperidino-propiophenone (tolperisone), pharmaceutical compositions containing the same, and agent formulations containing tolperisone
11/06/2008WO2008113756A8 Compounds having aryl-sulphonamidic structure useful as metalloproteases inhibitors
11/06/2008WO2008110698A3 Method for preparing fluorinated sulphanylamides and sulphinamidines and uses thereof
11/06/2008US20080275238 4-(Hydroxyalkyl-)-piperazinyl(thio)acetamide derivatives for treatment of cardiovascular disorders; antiarrhythmia agents; intermittent claudication, angina, congestive heart failure and myocardial infarction; diabetes
11/06/2008US20080275233 Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease
11/06/2008US20080275127 Arylsulfonamido-substituted hydroxamic acid derivatives
11/06/2008US20080275047 Tetrahydro-naphthalene derivatives
11/06/2008US20080275028 Modulators or Alpha7 Nicotinic Acetylcholine Receptors and Therapeutic Uses Thereof
11/06/2008US20080275003 Phospholipase inhibitor; prevention or therapy of microbial infection; bactericides; fungicides; viricides; parasiticides; using quaternary or phosphonium group containing compounds
11/06/2008CA2685507A1 Substituted sulfonamide derivatives
11/06/2008CA2685268A1 Compositions of tolperisone
11/06/2008CA2683634A1 Process for the production of high-purity 2,4'-dimethyl-3-piperidino-propiophenone (tolperisone), pharmaceutical compositions that contain the latter, as well as active ingredientformulations that contain tolperisone
11/05/2008EP1986749A2 Use of transmission dyes for protecting human skin from browning and ageing
11/05/2008EP1608374B1 2-phenoxy- and 2-phenylsulfomamide derivatives with ccr3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders
11/05/2008EP1324970B1 Retinoids for the treatment of emphysema
11/05/2008CN101300242A Processes for the preparation of cyclopropyl-amide derivatives
11/05/2008CN101300241A Piperazine derivatives as antimalarial agents
11/05/2008CN101298427A Diaryl urea compound and use thereof
11/05/2008CN100430386C Phenylalanine derivatives as depeptidyl peptidase inhibitors for the treatment or prevention of diabetes
11/05/2008CN100430385C Improvement in the storage stability of photoinitiators
11/05/2008CN100430377C N-alkyl phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease
11/05/2008CN100430052C Cathepsin cysteine protease inhibitors
11/04/2008US7446210 Factor Xa compounds
11/04/2008US7446115 To treat pain, drug addiction, or tinnitus; selectively inhibit sodium or calcium ion channels and agonize or antagonize mu -opioid receptors; N-Benzyl-N-(2-dimethylamino-ethyl)-2-(S)-[3-(4-fluorophenyl)-ureido]-3-methyl-butyramide
11/04/2008US7446109 Carbonylamino-derivatives as novel inhibitors of histone deacetylase
11/04/2008US7446104 Histamine receptor antagonists; 4-[3-(4-Piperidin-1-yl-but-1-ynyl)-benzyl]-thiomorpholine; antiallergens, antihistamines, antiepileptic agents; asthma, alzheimer's disease, narcolepsy, motion sickness, attention deficit disorder, schizophrenia
10/2008
10/30/2008WO2008131368A2 Styrenyl derivative compounds for treating ophthalmic diseases and disorders
10/30/2008WO2008130332A1 Subsituted sulphonamides, process for their preparation, pharmaceutical composition comprising thereof and their use
10/30/2008WO2008130323A1 Novel 8-piperazine-tetrahydronaphtalene derivatives for the treatment of pain
10/30/2008WO2008129288A2 Disulfonamides useful in the treatment of inflammation
10/30/2008WO2008022204A3 Thiourea compounds
10/30/2008WO2007126362A8 Compounds that are agonists of muscarinic receptors and that may be effective in treating pain, alzheimer's disease and/or schizophrenia
10/30/2008WO2007106439A3 Homotropanes with central nervous system activity
10/30/2008US20080269283 Arylsulfones and uses related thereto
1 ... 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 ... 341